Sec Form 13G Filing - BIGGER CAPITAL FUND L P filing for AEON Biopharma, Inc. (AEON) - 2025-01-08

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
BIGGER CAPITAL FUND L P
 
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member of Bigger Capital Fund GP, LLC, its general partner
Date:01/08/2025
 
Bigger Capital Fund GP, LLC
 
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:01/08/2025
 
District 2 Capital Fund LP
 
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member of District 2 GP LLC, its general partner
Date:01/08/2025
 
District 2 Capital LP
 
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:01/08/2025
 
District 2 GP LLC
 
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:01/08/2025
 
District 2 Holdings LLC
 
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:01/08/2025
 
Bigger Michael
 
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger
Date:01/08/2025
Exhibit Information

99.1 - Joint Filing Agreement

primary_doc.xml